Ppsv23
Streptococcus Pneumoniae
Poitiers University HospitalvaccinePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Streptococcus Pneumoniae cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Conjugated Pneumococcal Vaccine Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Phase 4 | BBB |
Prevenar 13 Poitiers University Hospital | Phase 4 | BBB |
Ppsv23 Poitiers University Hospital | Phase 4 | BB |
Prevnar 20 Poitiers University Hospital | Phase 4 | BB |
PCV 13 Pfizer | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Ppsv23 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →